360 related articles for article (PubMed ID: 17284626)
21. Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment.
Antoniazzi F; Bertoldo F; Lauriola S; Sirpresi S; Gasperi E; Zamboni G; Tatò L
J Clin Endocrinol Metab; 1999 Jun; 84(6):1992-6. PubMed ID: 10372699
[TBL] [Abstract][Full Text] [Related]
22. Can the TW3 bone age determination method provide additional criteria for growth hormone treatment in adopted girls with early puberty? A comparison of the Tanner-Whitehouse 3 method with the Greulich-Pyle and the Tanner-Whitehouse 2 methods.
Proos LA; Lönnerholm T; Jonsson B; Tuvemo T
Horm Res Paediatr; 2010; 73(1):35-40. PubMed ID: 20190538
[TBL] [Abstract][Full Text] [Related]
23. Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation.
Antoniazzi F; Zamboni G; Bertoldo F; Lauriola S; Mengarda F; Pietrobelli A; Tatò L
J Clin Endocrinol Metab; 2003 Mar; 88(3):1096-101. PubMed ID: 12629090
[TBL] [Abstract][Full Text] [Related]
24. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height.
Lazar L; Kauli R; Pertzelan A; Phillip M
J Clin Endocrinol Metab; 2002 May; 87(5):2090-4. PubMed ID: 11994346
[TBL] [Abstract][Full Text] [Related]
25. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
Lazar L; Pertzelan A; Weintrob N; Phillip M; Kauli R
J Clin Endocrinol Metab; 2001 Sep; 86(9):4127-32. PubMed ID: 11549638
[TBL] [Abstract][Full Text] [Related]
26. Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis.
Li P; Li Y; Yang CL
Medicine (Baltimore); 2014 Dec; 93(27):e260. PubMed ID: 25501098
[TBL] [Abstract][Full Text] [Related]
27. The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study.
Magiakou MA; Manousaki D; Papadaki M; Hadjidakis D; Levidou G; Vakaki M; Papaefstathiou A; Lalioti N; Kanaka-Gantenbein C; Piaditis G; Chrousos GP; Dacou-Voutetakis C
J Clin Endocrinol Metab; 2010 Jan; 95(1):109-17. PubMed ID: 19897682
[TBL] [Abstract][Full Text] [Related]
28. Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity.
Lazar L; Padoa A; Phillip M
J Clin Endocrinol Metab; 2007 Sep; 92(9):3483-9. PubMed ID: 17579199
[TBL] [Abstract][Full Text] [Related]
29. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
Poomthavorn P; Suphasit R; Mahachoklertwattana P
Gynecol Endocrinol; 2011 Aug; 27(8):524-8. PubMed ID: 21501002
[TBL] [Abstract][Full Text] [Related]
30. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
Lanes R; Gunczler P
Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
[TBL] [Abstract][Full Text] [Related]
31. [Effects of gonadotropin releasing hormone analog and growth hormone on height in girls with idiopathic central precocious puberty].
Wang CL; Liang L; Liu PN; Jin XJ; Chen LQ; Yang F; Lian Q; Chen RM
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jan; 16(1):25-30. PubMed ID: 24461173
[TBL] [Abstract][Full Text] [Related]
32. [Effect of gonadotropin-releasing hormone analog combined with stanazolol on final height in girls with idiopathic central precocious puberty and apparent decrease of linear growth].
Li YH; Zhu SY; Ma HM; Su Z; Chen HS; Chen QL; Gu YF; Du ML
Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):807-12. PubMed ID: 24484553
[TBL] [Abstract][Full Text] [Related]
33. Use of growth hormone and gonadotropin releasing hormone agonist in addition to L-thyroxine to attain normal adult height in two patients with severe Hashimoto's thyroiditis.
Quintos JB; Salas M
J Pediatr Endocrinol Metab; 2005 May; 18(5):515-21. PubMed ID: 15921183
[TBL] [Abstract][Full Text] [Related]
34. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study].
Yuan JN; Liang L; Cai XD; Li Z; Bai M; Gu CP
Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):896-9. PubMed ID: 22099200
[TBL] [Abstract][Full Text] [Related]
35. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty.
Boot AM; De Muinck Keizer-Schrama S; Pols HA; Krenning EP; Drop SL
J Clin Endocrinol Metab; 1998 Feb; 83(2):370-3. PubMed ID: 9467543
[TBL] [Abstract][Full Text] [Related]
36. The Beneficial Effect of Combined GH/GnRHa Therapy in Increasing Adult Height Outcome in Children With ISS.
Lazar L; Levy S; Oron T; Meyerovitch J; de Vries L; Shalitin S; Tenenbaum A; Phillip M; Lebenthal Y
J Clin Endocrinol Metab; 2019 Aug; 104(8):3287-3295. PubMed ID: 30912806
[TBL] [Abstract][Full Text] [Related]
37. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study.
Saggese G; Federico G; Barsanti S; Fiore L
J Clin Endocrinol Metab; 2001 May; 86(5):1900-4. PubMed ID: 11344181
[TBL] [Abstract][Full Text] [Related]
38. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
Toumba M; Bacopoulou I; Savva SC; Skordis N
Indian Pediatr; 2007 Jul; 44(7):497-502. PubMed ID: 17684302
[TBL] [Abstract][Full Text] [Related]
40. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial.
Mericq MV; Eggers M; Avila A; Cutler GB; Cassorla F
J Clin Endocrinol Metab; 2000 Feb; 85(2):569-73. PubMed ID: 10690857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
